Post-pandemic persistence of adverse health behaviors in patients with psychotic disorders: A follow-up study
Serkan Yazıcı,Ezgi Sıla Ahi,Rıfat Serav İlhan,Meram Can Saka
DOI: https://doi.org/10.1016/j.genhosppsych.2024.09.015
IF: 7.587
2024-10-02
General Hospital Psychiatry
Abstract:Objective The ramifications of the COVID-19 pandemic on patients with psychotic disorders have been previously documented by the authors of this study. The aim of study is to investigate whether the effects of the pandemic continued among the same cohort of patients with psychotic disorders who participated in the initial study. Methods 232 of the 255 participants in the initial study participated in this follow-up study. The assessment covered sociodemographic data, changes in physical and mental health since the pandemic, new diagnoses of physical illnesses, smoking, medication adherence, suicidal behavior. Results The body weight of the patients before, during, and after the pandemic was 77.6 ± 13.1,81.3 ± 14.1,and 83.1 ± 14.3, respectively and there was increase in BW in the post-pandemic compared to before the pandemc and the during the pandemic (Z: - 8.658, p < 0.001, r: -0.57; Z: −6.852, p < 0.001, r: ‐0.45 respectively). The mean number of cigarettes smoked daily by the patient's before the pandemic, during the pandemic, and after the pandemic was 11.1 ± 14.2,14.9 ± 16.2,and 12.9 ± 14.9, respectively. There was a decrease in the number of cigarettes smoked daily in the post-pandemic compared to the during the pandemic (Z: −4753, p < 0.001, r: −0.45). Both suicidal ideations and attempts were significantly higher during the pandemic compared to after the pandemic ( p < 0.001,p < 0.001). Medication adherence in the post-pandemic period was not different compared to the pandemic levels (Z: −0.621, p:0.535). Conclusion The study confirmed the continuation of adverse outcomes noted previously, such as increased body weight, increased daily cigarette consumption, and diminished medication adherence.
psychiatry